Back

Mitochondrial reverse electron transport in myeloid cells perpetuates neuroinflammation

Peruzzotti-Jametti, L.; Willis, C. M.; Hamel, R.; Krzak, G.; Reisz, J. A.; Prag, H. A.; Wu, V.; Xiang, Y.; van den Bosch, A.; Nicaise, A. M.; Roth, L.; Bates, G. R.; Huang, H.; Vincent, A. E.; Frezza, C.; Viscomi, C.; Marioni, J. C.; D'Alessandro, A.; Takats, Z.; Murphy, M. P.; Pluchino, S.

2024-01-04 neuroscience
10.1101/2024.01.03.574059 bioRxiv
Show abstract

Sustained smouldering, or low grade, activation of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis (MS)1. Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells2. However, how these metabolic features act to perpetuate neuroinflammation is currently unknown. Using a multiomics approach, we identified a new molecular signature that perpetuates the activation of myeloid cells through mitochondrial complex II (CII) and I (CI) activity driving reverse electron transport (RET) and the production of reactive oxygen species (ROS). Blocking RET in pro-inflammatory myeloid cells protected the central nervous system (CNS) against neurotoxic damage and improved functional outcomes in animal disease models in vivo. Our data show that RET in myeloid cells is a potential new therapeutic target to foster neuroprotection in smouldering inflammatory CNS disorders3.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.